Dietary isoflavones, urinary isoflavonoids, and risk of ischemic stroke in Women1-3

American Journal of Clinical Nutrition

Volumn 102, Issue 3, 2015, Pages 680-686

  Yu, Danxia ^a   Shu, Xiao Ou ^a   Li, Honglan ^b   Yang, Gong ^a   Cai, Qiuyin ^a   Xiang, Yong Bing ^c   Ji, Bu Tian ^c   Franke, Adrian A ^d   Gao, Yu Tang ^c   Zheng, Wei ^a   Zhang, Xianglan ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c NATIONAL CANCER INSTITUTE   (United States)

^d UNIVERSITY OF HAWAII CANCER CENTER   (United States)

Author keywords

Ischemic stroke; Phytoestrogen; Prospective cohort study; Soy isoflavone; Women

Indexed keywords

ANTIBIOTIC AGENT; ISOFLAVONE; ISOFLAVONE DERIVATIVE; ISOFLAVONOID;

ADULT; AGED; ARTICLE; BRAIN ISCHEMIA; CARDIOVASCULAR DISEASE; CASE CONTROL STUDY; CEREBROVASCULAR ACCIDENT; CHINESE; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DIETARY INTAKE; DRUG USE; FEMALE; FOLLOW UP; FOOD FREQUENCY QUESTIONNAIRE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HORMONAL THERAPY; HUMAN; INTERVIEW; INTESTINE FLORA; MAJOR CLINICAL STUDY; MASS SPECTROMETRY; MEDICAL RECORD; NEOPLASM; POSTMENOPAUSE; PROFESSIONAL PRACTICE; PROSPECTIVE STUDY; URINALYSIS; URINARY EXCRETION; VALIDATION STUDY; ASIAN CONTINENTAL ANCESTRY GROUP; CHEMISTRY; DIET; MIDDLE AGED; MULTIVARIATE ANALYSIS; NUTRITIONAL ASSESSMENT; QUESTIONNAIRE; RISK FACTOR; SOYBEAN; STROKE; URINE;

ADULT; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIET; FEMALE; FOLLOW-UP STUDIES; HUMANS; ISOFLAVONES; MIDDLE AGED; MULTIVARIATE ANALYSIS; NUTRITION ASSESSMENT; PROSPECTIVE STUDIES; RISK FACTORS; SOYBEANS; STROKE; SURVEYS AND QUESTIONNAIRES;

EID: 84941657557     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.3945/ajcn.115.111591     Document Type: Article

References (30)

1. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Blaha MJ, Dai S, Ford ES, Fox CS, Franco S, et al. Heart disease and stroke statistics-2014 update: a report from the American Heart Association. Circulation 2014;129:e28-292.
2. Bushnell C, McCullough LD, Awad IA, Chireau MV, Fedder WN, Furie KL, Howard VJ, Lichtman JH, Lisabeth LD, Pina IL, et al. Guidelines for the prevention of stroke in women: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2014;45:1545-88.
3. Wassertheil-Smoller S, Hendrix SL, Limacher M, Heiss G, Kooperberg C, Baird A, Kotchen T, Curb D, Black H, Rossouw JE, et al. Effect of estrogen plus progestin on stroke in postmenopausal women: The Women's Health Initiative: a randomized trial. JAMA 2003;289: 2673-84.
4. Hendrix SL, Wassertheil-Smoller S, Johnson KC, Howard BV, Kooperberg C, Rossouw JE, Trevisan M, Aragaki A, Baird AE, Bray PF, et al. Effects of conjugated equine estrogen on stroke in the Women's Health Initiative. Circulation 2006;113:2425-34.
5. Bushnell CD, Goldstein LB. Risk of ischemic stroke with tamoxifen treatment for breast cancer: a meta-analysis. Neurology 2004;63: 1230-3.
6. Barrett-Connor E, Mosca L, Collins P, Geiger MJ, Grady D, Kornitzer M, McNabb MA, Wenger NK. Effects of raloxifene on cardiovascular events and breast cancer in postmenopausal women. N Engl J Med 2006;355:125-37.
7. Sacks FM, Lichtenstein A, Horn LV, Harris W, Kris-Etherton P, Winston M. Soy protein, isoflavones, and cardiovascular health: an American Heart Association Science Advisory for professionals from the Nutrition Committee. Circulation 2006;113:1034-44.
8. Patisaul HB, Jefferson W. The pros and cons of phytoestrogens. Front Neuroendocrinol 2010;31:400-19.
9. Gencel VB, Benjamin MM, Bahou SN, Khalil RA. Vascular effects of phytoestrogens and alternative menopausal hormone therapy in cardiovascular disease. Mini Rev Med Chem 2012;12:149-74.
10. Anderson JW, Bush HM. Soy protein effects on serum lipoproteins: a quality assessment and meta-analysis of randomized, controlled studies. J Am Coll Nutr 2011;30:79-91.
11. Li S-H, Liu X-X, Bai Y-Y,Wang X-J, Sun K, Chen J-Z, Hui R-T. Effect of oral isoflavone supplementation on vascular endothelial function in postmenopausal women: a meta-analysis of randomized placebocontrolled trials. Am J Clin Nutr 2010;91:480-6.
12. Rios DRA, Rodrigues ET, Cardoso APZ, Montes MBA, Franceschini SA, Toloi MRT. Effects of isoflavones on the coagulation and fibrinolytic system of postmenopausal women. Nutrition 2008;24:120-6.
13. Kelly LA, O'Leary JJ, Seidlova-Wuttke D, Wuttke W, Norris LA. Genistein alters coagulation gene expression in ovariectomised rats treated with phytoestrogens. Thromb Haemost 2010;104:1250-7.
14. Yu D, Zhang X, Xiang Y-B, Yang G, Li H, Fazio S, Linton M, Cai Q, Zheng W, Gao Y-T, et al. Association of soy food intake with risk and biomarkers of coronary heart disease in Chinese men. Int J Cardiol 2014;172:e285-7.
15. van der Schouw YT, Kreijkamp-Kaspers S, Peeters PHM, Keinan-Boker L, Rimm EB, Grobbee DE. Prospective study on usual dietary phytoestrogen intake and cardiovascular disease risk in western women. Circulation 2005;111:465-71.
16. Mink PJ, Scrafford CG, Barraj LM, Harnack L, Hong C-P, Nettleton JA, Jacobs DR. Flavonoid intake and cardiovascular disease mortality: a prospective study in postmenopausal women. Am J Clin Nutr 2007; 85:895-909.
17. McCullough ML, Peterson JJ, Patel R, Jacques PF, Shah R, Dwyer JT. Flavonoid intake and cardiovascular disease mortality in a prospective cohort of US adults. Am J Clin Nutr 2012;95:454-64.
18. Kokubo Y, Iso H, Ishihara J, Okada K, Inoue M, Tsugane S. Association of dietary intake of soy, beans, and isoflavones with risk of cerebral and myocardial infarctions in japanese populations: the Japan Public Health Center-based (JPHC) study cohort I. Circulation 2007; 116:2553-62.
19. Nagata C, Takatsuka N, Shimizu H. Soy and fish oil intake and mortality in a Japanese community. Am J Epidemiol 2002;156:824-31.
20. Talaei M, Koh W-P, van Dam RM, Yuan J-M, Pan A. Dietary soy intake is not associated with risk of cardiovascular disease mortality in Singapore Chinese adults. J Nutr 2014;144:921-8.
21. Zheng W, Chow W-H, Yang G, Jin F, Rothman N, Blair A, Li H-L, Wen W, Ji B-T, Li Q, et al. The Shanghai Women's Health Study: rationale, study design, and baseline characteristics. Am J Epidemiol 2005;162:1123-31.
22. Yang Y, Wang G, Pan X, editors. Chinese food composition 2002. Beijing (China): Peking University Medical Press; 2002.
23. Shu XO, Yang G, Jin F, Liu D, Kushi L, Wen W, Gao Y-T, Zheng W. Validity and reproducibility of the food frequency questionnaire used in the Shanghai Women's Health Study. Eur J Clin Nutr 2004;58: 17-23.
24. Walker AE, Robins M, Weinfeld FD. The National Survey of Stroke. Clinical findings. Stroke 1981;12:I13-44.
25. Franke AA, Halm BM, Kakazu K, Li X, Custer LJ. Phytoestrogenic isoflavonoids in epidemiologic and clinical research. Drug Test Anal 2009;1:14-21.
26. Willett WC, Howe GR, Kushi LH. Adjustment for total energy intake in epidemiologic studies. Am J Clin Nutr 1997;65:1220S-8S.
27. Wickham H. ggplot2: elegant graphics for data analysis [Internet]. New York: Springer; 2009 [cited 2014 Aug 18]. Available from: http://had. co.nz/ggplot2/book.
28. Lampe JW, Chang J-L. Interindividual differences in phytochemical metabolism and disposition. Semin Cancer Biol 2007;17:347-53.
29. Lampe JW. Is equol the key to the efficacy of soy foods? Am J Clin Nutr 2009;89:1664S-7S.
30. Shor D, Sathyapalan T, Atkin SL, Thatcher NJ. Does equol production determine soy endocrine effects? Eur J Nutr 2012;51:389-98.